Eli Lilly Stock Surges on Obesity Treatment Outlook

Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Tuesdays

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored
Podcast artwork

Categories:

Business

Eli Lillys stock surged following Leerink Partners upgrade to Outperform, raising price target to $1,104, driven by anticipated obesity treatment adoption and Medicare/Medicaid expansion. Shares closed at $969.48, a 4.9% increase, marking a new fifty-two-week high and a 24.6% YTD gain. Long-term investors have seen a sixfold return over five years.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site